Phoenix Bio

PXB-Mouse

PXB-mouse関連の論文実績

DMPK & Toxicology

Chimeric mice with humanized livers demonstrate human-specific hepatotoxicity caused by a therapeutic antibody against TRAIL-receptor 2/death receptor 5
Nihira, K. Nan-Ya, K. I. Kakuni, M. Ono, Y. Yoshikawa, Y. Ota, T. Hiura, M. Yoshinari, K. Toxicol Sci. 2019 Jan 1;167(1):190-201. READ MORE
Chimeric mice with human hepatocytes: A new system for genotoxicity studies
Tateno, C. Fukumuro, M. Masumori, S. Kakuni, M. Ishida, Y. Shimada, T. Hayashi, M. Mutat Res. 2019 Mar;839:9-12. READ MORE
The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice
de la Rosa Rodriguez, M. A. Sugahara, G. Hooiveld, Gjej Ishida, Y. Tateno, C. Kersten, S.
BMC Genomics. 2018 Jun 7;19(1):443
READ MORE
Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver
Sanoh, S. Yamachika, Y. Tamura, Y. Kotake, Y. Yoshizane, Y. Ishida, Y. Tateno, C. Ohta, S.
J Toxicol Sci. 2017;42(5):589-96
 READ MORE
Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin
Okuda, Y. Kushida, M. Kikumoto, H. Nakamura, Y. Higuchi, H. Kawamura, S. Cohen, S. M. Lake, B. G. Yamada, T.
J Toxicol Sci. 2017;42(6):773-88
 READ MORE
Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice
Ohara A , Takahashi Y,  Kondo  M,  Okuda Y, Takeda  S,  Kushida M, Kobayashi  K,  Sumida K, Yamada T
Toxicol Res (Camb). 2017 Aug 24;6(6):795-813
READ MORE
Halogenated hydrocarbon solvent-related cholangiocarcinoma risk: biliary excretion of glutathione conjugates of 1,2-dichloropropane evidenced by untargeted metabolomics analysis
Toyoda, Y. Takada, T. Suzuki, H.
Sci Rep. 2016 Apr 18;6:24586
 READ MORE
Zone analysis by two-dimensional electrophoresis with accelerator mass spectrometry of in vivo protein bindings of idiosyncratic hepatotoxicants troglitazone and flutamide bioactivated in chimeric mice with humanized liver
Yamazaki, Hiroshi, Kuribayashi, Shunji Inoue, Tae Honda, Tomohiro Tateno, Chise Oofusa, Ken Ninomiya, Shinichi Ikeda, ToshihikoIzumi, Takashi Horie, Toru
Toxicol. Res. ,2015, 4:106–11
 READ MORE
Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator-activated Receptor-alpha
Tateno, C. Yamamoto, T. Utoh, R. Yamasaki, C. Ishida, Y. Myoken, Y. Oofusa, K. Okada, M. Tsutsui, N. Yoshizato, K.
Toxicol Pathol. 2015 Feb;43(2):233-48
READ MORE
Human Hepatocytes Support the Hypertrophic but not the Hyperplastic Response to the Murine Nongenotoxic Hepatocarcinogen Sodium Phenobarbital in an In Vivo Study Using a Chimeric Mouse with Humanized Liver
Yamada, T. Okuda, Y. Kushida, M. Sumida, K. Takeuchi, H. Nagahori, H. Fukuda, T. Lake, B. G. Cohen, S. M. Kawamura, S.
Toxicol Sci. 2014 Nov;142(1):137-57
READ MORE
Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone
Barnes, A. J. Baker, D. R. Hobby, K. Ashton, S. Michopoulos, F. Spagou, K.Loftus, N. J. Wilson, I. D.
Xenobiotica. 2014 Jan;44(2):174-85
READ MORE
Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers
Schulz-Utermoehl, T. Sarda, S. Foster, J. R. Jacobsen, M. Kenna, J. G. Morikawa, Y. Salmu, J. Gross, G. Wilson, I. D.
Xenobiotica. 2012 Jun;42(6):503-17
 READ MORE
Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury
Kakuni, M. Morita, M. Matsuo, K. Katoh, Y. Nakajima, M. Tateno, C. Yokoi, T.
Toxicol Lett. 2012 Oct 2;214(1):9-18
READ MORE

 

DMPK

Prediction of human pharmacokinetics of long half-life compounds using chimeric mice with humanised liver
Miyamoto, M. Iwasaki, S. Chisaki, I. Nakagawa, S. Amano, N. Kosugi, Y. Hirabayashi, H.
Xenobiotica. 2019 Dec;49(12):1379-1387.
READ MORE
Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver
Sanoh, S. Tamura, Y. Fujino, C. Sugahara, G. Yoshizane, Y. Yanagi, A. Kisoh, K. Ishida, Y. Tateno, C. Ohta, S. Kotake, Y.
Biol Pharm Bull. 2019;42(8):1366-1375.
Changes in Bile Acid Concentrations in Chimeric Mice Transplanted with Different Replacement Indexes of Human Hepatocytes
Fujino C, Sanoh S,* Tamura Y, Ishida Y, Tateno C, Ohta S and  Kotakea Y
BPB Reports 2, 29-34 (2019)
READ MORE
Organic anion transporting polypeptides (OATPs)-mediated drug-drug interaction study between rosuvastatin and cyclosporine A in chimeric mice with humanized liver
Uchida, M. Tajima, Y. Kakuni, M. Kageyama, Y. Okada, T. Sakudara, E. Tateno, C. Hayashi, R.
Drug Metab Dispos. 2018 Jan;46(1):11-19.
READ MORE
Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions
Takaoka, N. Sanoh, S. Okuda, K. Kotake, Y. Sugahara, G. Yanagi, A. Ishida, Y. Tateno, C. Tayama, Y. Sugihara, K. Kitamura, S. Kurosaki, M. Terao, M. Garattini, E. Ohta, S.
Biochem Pharmacol. 2018 Aug;154:28-38
READ MORE
FXR Activation by Obeticholic Acid or Non-Steroidal Agonists Induces a Human-Like Lipoprotein Cholesterol Change in Mice with Humanized Chimeric Liver
Papazyan, R. Liu, X. Liu, J. Dong, B. Plummer, E. M. Lewis, R. D., 2nd Roth, J. D. Young, M. A.
J Lipid Res. 2018 Jun;59(6):982-93
READ MORE
Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver
Miyamoto, M. Iwasaki, S.  Chisaki, I. Nakagawa, S. Amano, N. Hirabayashi, H.
Xenobiotica. 2017 Dec;47(12):1052-63
READ MORE
Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans
Nakada, N. Kawamura, A. Kamimura, H. Sato, K. Kazuki, Y. Kakuni, M. Ohbuchi, M. Kato, K. Tateno, C. Oshimura, M. Usui, T.
Biopharm Drug Dispos. 2016 Jan;37(1):3-14
READ MORE
Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
Kato, K. Ohbuchi, M. Hamamura, S. Ohshita, H. Kazuki, Y. Oshimura, M. Sato, K. Nakada, N. Kawamura, A. Usui, T. Kamimura, H. Tateno, C.
Drug Metab Dispos. 2015 Aug;43(8):1208-17
READ MORE
Application of Chimeric Mice with Humanized Liver for Study of Human-Specific Drug Metabolism
Bateman, T. Reddy, V. B. Kakuni, M. Morikawa, Y. Kumar, S.
Drug Metab Dispos. 2014 Jun;42(6):1055-65
READ MORE
Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS
Ohtsuki, S. Kawakami, H. Inoue, T. Nakamura, K. Tateno, C. Katsukura, Y. Obuchi, W. Uchida, Y. Kamiie, J. Horie, T. Terasaki, T.
Drug Metab Dispos June 2014 42:1039-43
READ MORE
Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes
Sanoh, S. Nozaki, K. Murai, H. Terashita, S. Teramura, T. Ohta, S.
Drug Metab Dispos. 2012 Jan;40(1):76-82
READ MORE
Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers
Samuelsson, K. Pickup, K. Sarda, S. Swales, J. G. Morikawa, Y. Schulz-Utermoehl, T. Hutchison, M. Wilson, I. D.
Xenobiotica. 2012 Nov;42(11):1128-37
READ MORE
Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver
Hasegawa, M. Tahara, H. Inoue, R. Kakuni, M. Tateno, C. Ushiki, J.
Drug Metab Dispos. 2012 Mar;40(3):474-80.
READ MORE
Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism
De Serres, M. Bowers, G. Boyle, G. Beaumont, C. Castellino, S. Sigafoos, J. Dave, M. Roberts, A. Shah, V. Olson, K. Patel, D. Wagner, D. Yeager, R. Serabjit-Singh, C.
Xenobiotica. 2011 Jun;41(6):464-75
READ MORE
Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice
Shoda, J. Okada, K. Inada, Y. Kusama, H. Utsunomiya, H. Oda, K. Yokoi, T. Yoshizato, K. Suzuki, H.
Hepatol Res. 2007 Jul;37(7):548-56
READ MORE
Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver
Nishimura, M. Yoshitsugu, H. Yokoi, T. Tateno, C. Kataoka, M. Horie, T. Yoshizato, K. Naito, S.
Xenobiotica. 2005 Sep;35(9):877-90
READ MORE
In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver
Katoh, M. Matsui, T. Nakajima, M. Tateno, C. Soeno, Y. Horie, T. Iwasaki, K. Yoshizato, K. Yokoi, T.
Drug Metab Dispos. 2005 Jun;33(6):754-63
READ MORE
Expression of human phase II enzymes in chimeric mice with humanized liver
Katoh, M. Matsui, T. Okumura, H. Nakajima, M. Nishimura, M. Naito, S.Tateno, C. Yoshizato, K. Yokoi, T.
Drug Metab Dispos. 2005 Sep;33(9):1333-40
READ MORE
Near completely humanized liver in mice shows human-type metabolic responses to drugs
Tateno, C. Yoshizane, Y. Saito, N. Kataoka, M. Utoh, R. Yamasaki, C. Tachibana, A. Soeno, Y. Asahina, K. Hino, H. Asahara, T. Yokoi, T. Furukawa, T. Yoshizato, K.
Am J Pathol. 2004 Sep;165(3):901-12.
READ MORE

 

HBV

An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People
Hayashi, S. Khan, A. Simons, B. C. Homan, C. Matsui, T. Ogawa, K. Kawashima, K. Murakami, S. Takahashi, S. Isogawa, M. Ikeo, K. Mizokami, M. McMahon, B. J. Tanaka, Y.
Hepatology. 2019 Jan;69(1):19-33.
READ MORE
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients
Nomura, M. Tsuge, M. Uchida, T. Hiraga, N. Kurihara, M. Tsushima, K. Fujino, H. Nakahara, T. Murakami, E. Abe-Chayama, H. Kawaoka, T. Miki, D. Hiramatsu, A. Imamura, M. Kawakami, Y. Aikata, H. Ochi, H. Zhang, Y. Makokha, G. N. Hayes, C. N. Tanaka, S. Chayama, K.
J Viral Hepat. 2018 Jul 11.
READ MORE
ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection
Thi, E. P. Dhillon, A. P. Ardzinski, A. Bidirici-Ertekin, L. Cobarrubias, K. D. Cuconati, A. Kondratowicz, A. S. Kwak, K. Li, A. H. L. Miller, A. Pasetka, C. Pei, L.Phelps, J. R. Snead, N. M. Wang, X. Ye, X. Sofia, M. J. Lee, A. C. H.
Gastroenterology. 2018 Feb;154(3):652-662
READ MORE
Efficacy of NVR 3-778, Alone and in Combination With Pegylated Interferon, vs Entecavir in uPA/SCID Mice With Humanized Livers and HBV Infection
Klumpp, K. Shimada, T. Allweiss, L. Volz, T. Lutgehetmann, M. Hartman, G. Flores, O. A. Lam, A. M. Dandri, M.
Gastroenterology. 2018 Feb;154(3):652-662
READ MORE
Acute HBV infection in humanized chimeric mice has multiphasic viral kinetics
Ishida, Y. Chung, T. L. Imamura, M. Hiraga, N. Sen, S. Yokomichi, H. Tateno, C. Canini, L. Perelson, A. S. Uprichard, S. L. Dahari, H. Chayama, K.
Hepatology. 2018 Aug;68(2):473-484
READ MORE
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
Furuta, M. Tanaka, H. Shiraishi, Y. Unida, T. mamura, M. Fujimoto, A. Fujita, M. Sasaki-Oku, A. Maejima, K. Nakano, K. Kawakami, Y. Arihiro, K. Aikata, H. Ueno, M. Hayami, S. Ariizumi, S. I. Yamamoto, M. Gotoh, K. Ohdan, H. Yamaue, H. Miyano, S. Chayama, K. Nakagawa, H.
Oncotarget. 2018 May 18;9(38):25075-25088.
READ MORE
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus
Tsuge, M. Uchida, T. Hiraga, N. Kan, H. Makokha, G. N. Abe-Chayama, H. Miki, D. Imamura, M. Ochi, H. Hayes, C. N. Shimozono, R. Iwamura, T.Narumi, H. Suzuki, T  Kainoh, M. Taniguchi, T. Chayama, K.
Antimicrob Agents Chemother. 2017 May 24;61(6).
READ MORE
The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection
Niu, C. Livingston, C. M. Li, L. Beran, R. K. Daffis, S. Ramakrishnan, D. Burdette, D. Peiser, L. Salas, E. Ramos, H. Yu, M. Cheng, G. Strubin, M. Delaney Iv, W. E. Fletcher, S. P.
PLoS One. 2017 Jan 17;12(1):e0169648
READ MORE
A Novel Orally Available Small Molecule That Inhibits Hepatitis B Virus Expression
Mueller, H. Wildum, S. Luangsay, S. Walther, J. Lopez, A. Tropberger, P. Ottaviani, G. Lu, W. John Parrott, N. Zhang, J. D. Schmucki, R. Racek, T. Hoflack, J. C. Kueng, E. Point, F. Zhou, X. Steiner, G. Lutgehetmann, M. Rapp, G. Volz, T. Dandri, M. Yang, S. Young, J. A. T. Javanbakht, H.
J Hepatol. 2018 Mar;68(3):412-420
READ MORE
Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages
Cheng, X. Xia, Y. Serti, E. Block, P. D. Chung, M. Chayama, K. Rehermann, B. Liang, T. J.
Hepatology. 2017 Dec;66(6):1779-1793
 READ MORE
Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection
Tsuge, M. Hiraga, N. Uchida, T. Kan, H. Miyaki, E. Masaki, K. Ono, A. Nakahara, T. Abe-Chayama, H. Zhang, Y. Naswa, M. G. Kawaoka, T. Miki, D. Imamura, M. Kawakami, Y. Aikata, H. Ochi, H. Hayes, C. N. Chayama, K.
J Gastroenterol. 2016 Nov;51(11):1073-1080
READ MORE
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Decorsiere, A. Mueller, H. van Breugel, P. C. Abdul, F. Gerossier, L. Beran, R. K. Livingston, C. M. Niu, C. Fletcher, S. P. Hantz, O. Strubin, M.
Nature. 2016 Mar 17;531(7594):386-9
 READ MORE
Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
Komatsu, H. Inui, A. Murano, T. Tsunoda, T. Sogo, T. Fujisawa, T.
BMC Res Notes. 2015 Aug 20;8:366
 READ MORE
HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice
Tsuge, M. Hiraga, N. Akiyama, R. Tanaka, S. Matsushita, M. Mitsui, F. Abe, H. Kitamura, S. Hatakeyama, T. Kimura, T. Miki, D. Mori, N. Imamura, M. Takahashi, S. Hayes, C. N. Chayama, K.
J Gen Virol. 2010 Jul;91(Pt 7):1854-64.
 READ MORE

 

HCV

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease Development
Lupberger, J. Croonenborghs, T. Roca Suarez, A. A. Van Renne, N. Juhling, F. Oudot, M. A. Virzi, A. Bandiera, S. Jamey, C. Meszaros, G. Brumaru, D. Mukherji, A. Durand, S. C. Heydmann, L. Verrier, E. R. El Saghire, H. Hamdane, N. Bartenschlager, R. Fereshetian, S. Ramberger, E. Sinha, R. Nabian, M. Everaert, C. Jovanovic, M. Mertins, P. Carr, S. A. Chayama, K. Dali-Youcef, N. Ricci, R. Bardeesy, N. M. Fujiwara, N. Gevaert, O. Zeisel, M. B. Hoshida, Y. Pochet, N. Baumert, T. F.
Gastroenterology. 2019 Aug;157(2):537-551.e9.
 READ MORE
HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Hamdane, N. Juhling, F. Crouchet, E. El Saghire, H. Thumann, C. Oudot, M. A. Bandiera, S. Saviano, A. Ponsolles, C. Roca Suarez, A. A. Li, S. Fujiwara, N. Ono, A. Davidson, I. Bardeesy, N. Schmidl, C. Bock, C. Schuster, C. Lupberger, J. Habersetzer, F. Doffoel, M. Piardi, T. Sommacale, D. mamura, M. Uchida, T. Ohdan, H. Aikata, H. Chayama, K. Boldanova, T. Pessaux, P. Fuchs, B. C. Hoshida, Y. Zeisel, M. B. Duong, F. H. T. Baumert, T. F.
Gastroenterology. 2019 Jun;156(8):2313-2329.e7.
READ MORE
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Teraoka, Y. Uchida, T. Imamura, M. Osawa, M. Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Aikata, H. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.
Biochem Biophys Res Commun. 2018 Jun 2;500(2):152-157.
READ MORE
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology
Uchida, T. Imamura, M. Kan, H. Hiraga, N. Hayes, C. N. Tsuge, M. Abe-Chayama, H. Aikata, H. Makokha, G. N. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.
J Gen Virol. 2017 May;98(5):1040-1047
 READ MORE
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
Miyaki, E. Hiraga, N. Imamura, M. Uchida, T.  Kan, H.  Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Serikawa, M. Aikata, H. Ochi, H. Ishida, Y. Tateno, C. Ohdan, H. Chayama, K.
PLoS One. 2017 Mar 2;12(3):e0172412
 READ MORE
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus
Hamana, A. Takahashi, Y. Uchida, T. Nishikawa, M. Imamura, M. Chayama, K. Takakura, Y.
Antiviral Res.2017 Oct;146:130-138
 READ MORE
Critical role of CREBH-mediated induction of TGF-beta2 by HCV infection in fibrogenic responses in hepatic stellate cells
Chida, T. Ito, M. Nakashima, K. Kanegae, Y. Aoshima, T. Takabayashi, S. Kawata, K. Nakagawa, Y. Yamamoto, M. Shimano, H. Matsuura, T. Kobayashi, Y. Suda, T. Suzuki, T.
Hepatology. 2017 Nov;66(5):1430-1443
 READ MORE
Protease inhibitor resistance remains even after mutant strains become undetectable using deep sequencing
Kan, H. Imamura, M. Uchida, T. Hiraga, N. Hayes, C. N. Tsuge, M. Abe, H. Aikata, H. Makokha, G. N. Chowdhury, S. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.
J Infect Dis. 2016 Dec 1;214(11):1687-1694
 READ MORE
In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus
Watanabe, T. Hatakeyama, H. Matsuda-Yasui, C. Sato, Y. Sudoh, M. Takagi, A. Hirata, Y. Ohtsuki, T. Arai, M. Inoue, K. Harashima, H. Kohara, M.
Sci Rep. 2014 Apr 23;4:4750
 READ MORE
Hepatitis C Virus Core Protein Suppresses Mitophagy by Interacting with Parkin in the Context of Mitochondrial Depolarization
Hara, Y. Yanatori, I. Ikeda, M. Kiyokage, E. Nishina, S. Tomiyama, Y. Toida, K. Kishi, F. Kato, N. Imamura, M. Chayama, K. Hino, K.
Am J Pathol. 2014 Nov;184(11):3026-39
 READ MORE
Hepatitis C virus kinetics by administration of pegylated interferon-alpha in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene
Watanabe, T. Sugauchi, F. Tanaka, Y. Matsuura, K. Yatsuhashi, H. Murakami, S. Iijima, S. Iio, E. Sugiyama, M. Shimada, T. Kakuni, M. Kohara, M. Mizokami, M.
Gut. 2013 Sep;62(9):1340-6
 READ MORE
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Sainz, B., Jr. Barretto, N. Martin, D. N. Hiraga, N. Imamura, M. Hussain, S. Marsh, K. A. Yu, X. Chayama, K. Alrefai, W. A. Uprichard, S. L.
Nat Med. 2012 Jan 8;18(2):281-5
 READ MORE
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Lupberger, J. Zeisel, M. B. Xiao, F. Thumann, C. Fofana, I. Zona, L. Davis, C. Mee, C. J. Turek, M. Gorke, S. Royer, C. Fischer, B. Zahid, M. N. Lavillette, D. Fresquet, J. Cosset, F. L. Rothenberg, S. M. Pietschmann, T. Patel, A. H.Pessaux, P. Doffoel, M. Raffelsberger, W. Poch, O. McKeating, J. A. Brino, L. Baumert, T. F.
Nat Med. 2011 May;17(5):589-95
 READ MORE